JVP, AstraZeneca agree to identify, develop and invest in digital health
Jerusalem Venture Partners and the Cambridge, UK-based English-Swedish pharmaceutical and biopharmaceutical company AstraZeneca plc signed a cooperation agreement on Tuesday to identify, develop and invest in digital health in Israel.
You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.
Click ‘cancel’ to return to AstraZeneca’s site or ‘continue’ to proceed.
You are about to access AstraZeneca historic archive material. Any reference in these archives to AstraZeneca products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. Please refer to your approved national product label (SmPC) for current product information.
I have read this warning and will not be using any of the contained product information for clinical purposes.